Articles tagged with Cancer
Researchers from China have developed a novel bioconjugate that can suppress the growth of K-Ras mutant pancreatic tumors. The conjugate, which targets folate receptors and macropinocytosis, was found to be highly cytotoxic and effective at suppressing tumor growth.
A 58-year-old woman from Armenia suffered from severe finger pain for over 40 years when knitting, which was later revealed to be caused by a rare benign glomus tumor under her fingernail. The tumor was successfully removed in a 30-minute operation, restoring the patient's quality of life and allowing her to return to her hobby.
A randomized clinical trial found that smokers who received cigarette packs with graphic warning labels hid their packs 38% more often. However, when they returned to regular packs without the labels, hiding behavior returned to baseline levels. The study suggests that graphic warnings may not be effective in reducing smoking behavior.
A systematic review of 155 head and neck cancer clinical trials from 2010 to 2020 revealed that only 57% of studies reported race or ethnicity. Black and Asian or Pacific Islander patients were disproportionately underrepresented in these trials, highlighting a significant issue in the field.
Researchers have identified new biomarkers to detect non-small cell lung cancer in its early stages through a blood test, offering improved survival chances. The approach can also identify potential drug resistance, allowing clinicians to choose alternative treatment options.
Researchers discovered that leukemia-initiating cells in MLL-rearranged B-ALL can switch between two metabolic states, which makes them difficult to target. Targeting the quiet, stem cell-like state curbs the leukemia by forcing the cells back to an active proliferation state.
Researchers from CiQUS and Karolinska Institutet develop a new immunotherapeutic approach against cancer by blocking adenosine A2B receptors. The study demonstrates that this blockade reactivates the immune system, restoring its effectiveness against tumors.
A meta-analysis published in The Lancet Oncology suggests that targeted radiation therapy, which spares healthy brain tissue, is equitable to whole brain radiation therapy for patients with small cell lung cancer and brain metastases. This approach may improve their care experience with fewer negative cognitive consequences.
Despite the US leading in cancer care spending, it doesn't show substantial lower cancer mortality rates compared to other high-income countries. Cancer care spending across 22 high-income countries reveals a lack of correlation with cancer-related mortality rates.
Kaiser Permanente researchers present 10 studies on improving cancer care delivery, including strategies to reduce hospitalizations and mortality among older patients. The studies also explore the use of real-world data versus clinical trials in cancer treatment.
Researchers have found that mutational signatures, which reflect a collection of mutations across the genome, can accurately predict drug response in cancer cells. The study suggests that these signatures may hold the key to better cancer therapies and could be used to predict treatment response.
Recent research by scientists at Duke University has found that ordinary silicone wristbands can absorb semi-volatile organic compounds firefighters are exposed to while working, tracking their risk of cancer. The study reveals strong associations between active firefighting and exposure to certain contaminants.
A systematic review of qualitative studies found that rural patients experience significant challenges in accessing health care services for chronic conditions. Cultural, structural, and individual factors influence these experiences, highlighting the need for culturally appropriate interventions to improve access to care.
A study by researchers at UCSF found that e-cigarette use costs the US $15 billion annually in healthcare expenditures, with each user paying around $2,000 extra per year compared to non-users. The study, published in Tobacco Control, highlights the growing concern over health care costs associated with e-cigarette use.
A study found substantial decreases in cancer death rates among Black individuals in the US from 1999 to 2019. These declines were most pronounced for certain types of cancer, such as colorectal and stomach cancer.
A recent study found that 70% of adults with stage 3 or 4 cancer were at risk of drug-drug interactions, highlighting the importance of deprescribing medications to avoid harm. The study's results emphasize the need for education and problem-solving to address polypharmacy in older adults with cancer.
Researchers at Gwangju Institute of Science and Technology have developed a new bioinformatics pipeline, CRESSP, to investigate the mechanism underlying autoimmune diseases following SARS-CoV-2 infection. The tool identified potential epitopes responsible for COVID-related autoimmune diseases and predicted cross-reactive epitopes of di...
A recent study found that previous therapy interventions, including ACT, did not spare cancer survivors from increased anxiety during the COVID-19 pandemic. Researchers found that anxiety symptoms worsened over time, with participants who received ACT intervention performing worse than those who received usual care.
A recent study published in Breast Cancer Research suggests that self-reported male infertility may be associated with an increased risk of invasive breast cancer. The researchers conducted a case-control study among 1,998 males diagnosed with breast cancer, comparing them to 1,597 control males without blood relatives. The study found...
A recent study analyzed a large database of bladder cancer patients and found that fewer than half had been tested for the relevant gene mutation or received erdafitinib treatment, despite its proven efficacy. The research highlights significant barriers to treatment, including obstacles in testing and education for healthcare providers.
A novel connection between genes involved in mitosis and glucose metabolism was found by researchers at Nagoya University. They demonstrated a gene bypass process using evolutionary repair experiments, suggesting that suppressing both Plk1 and CK1 could be more effective in cancer treatment.
A new study published in the Journal of the National Comprehensive Cancer Network (JNCCN) found that incorporating the Electronic Health Record-Enabled Evidence-Based Smoking Cessation Treatment (ELEVATE) program into electronic health records can significantly improve smoking cessation rates among cancer patients. The research demonst...
Researchers modeled tumor evolution and found a tradeoff between growth advantage and immune evasion, suggesting certain mutations be ideal targets for precision immunotherapies. This could help prevent cancer emergence in people with inherited proclivity for malignancy.
A new type of RNA structure targeting tool has been developed to specifically recognise unusual four-strand RNA structures associated with diseases such as cancer and neurological disorders. The L-RNA aptamer-based rG4 targeting approach shows promise for developing new therapeutic tools.
Chronic bacterial infections can lead to chronic inflammation and DNA damage, increasing CRC risk. Salmonella infections are particularly risky, as they impair immune responses and promote tumorigenesis.
A systematic review and meta-analysis of 81 studies found that COVID-19 patients with cancer had a higher risk of death compared to those without cancer. Younger age, lung, and hematologic cancers were identified as risk factors for poor outcomes from COVID-19
A new study from the University of Warwick has identified a critical step in cancer formation during cell division, where chromosomes get trapped in membranes that prevent proper sharing. This discovery suggests that preventing this process may be a way to treat disease and could lead to more effective cancer prevention.
A new study finds that many children's products, including those labeled as water- or stain-resistant, contain harmful PFAS chemicals. The research highlights the need for stricter safety standards in green certifications and retailer accountability to prevent toxic chemical pollution.
A recent study published in Pharmacology & Therapeutics provides an in-depth description of the anti-cancer activity of sustained release capsaicin formulations. The research team found that capsaicin displayed robust growth-inhibitory activity in a diverse array of human cancers, but its clinical applications were hindered by poor sol...
Researchers have used a data-sharing innovation to categorise 16 uncertain BRCA variants as benign or likely benign, potentially allowing women with these variants to skip invasive surgeries. This could lead to thousands of people avoiding difficult treatments for no reason.
Cancer cells employ a unique defense mechanism to evade the effects of radiation treatment by exploiting an enzyme called Caspase-activated DNase (CAD). Removing CAD from cancer cells increases the effectiveness of radiotherapy. Researchers hope their discovery can lead to the development of targeted drugs to enhance cancer treatment.
The University at Buffalo is developing new treatments for ovarian cancer by targeting the apelin receptor. Ovarian cancer cells rely on lipids for energy and survival, making this a promising therapeutic target.
Researchers are refining COBRA, a repair robot inspired by snakes, for medical use in throat cancer and injury surgery. The robot offers more dexterity, accuracy, and high-definition views for surgical teams.
A recent study found that an artificial intelligence-based system improved providers' assessments of bladder cancer patients' response to chemotherapy. The AI tool helped doctors from different specialties and experience levels make more accurate diagnoses, with those in academia showing the greatest gains.
A novel pancreatic carcinogenesis model in wild-type rats was established using the pancreas-targeted selective hydrodynamic gene delivery method. The KRAS G12D-induced lesions showed malignant transformation and developed into pancreatic ductal adenocarcinoma within five weeks.
The Endocrine Society's scientific statement highlights the potential of extracellular vesicles in diagnosing and monitoring endocrine-related conditions, including cancer. These tiny vesicles may also serve as biomarkers for high blood pressure and have therapeutic roles.
A recent study published in Neuro-Oncology found that genomic profiling led to more aggressive patient management resulting in improved clinical outcomes compared to traditional biologically matched historical cohorts.
A large-scale analysis of over 12,000 cancers identifies new, rare mutational signatures that can enhance personalized cancer treatments and diagnoses. The study reveals a complex landscape of genetic mutations in cancer genomes.
A new study reveals a gene called KLF4 that normally suppresses tumor formation but is reprogrammed in acute promyelocytic leukemia, an aggressive type of blood cancer. Overexpressing KLF4 can suppress the growth of cancerous cells and reverse the effects of the disease.
The ESMO Breast Cancer Congress 2022 event will present more than 200 studies on various aspects of breast cancer, including new treatments and innovative clinical practices. The congress will be held onsite in Berlin, Germany, and online, offering a platform for breast cancer specialists to share knowledge and improve patient outcomes.
Researchers have shed light on how immune checkpoint protein LAG3 modulates T cell activity, providing crucial information for the development of new LAG3-blocking therapies. The study found that LAG3 suppresses T cell activation by disrupting coreceptor-Lck association, even in the absence of MHC Class II molecules.
A UCLA-led team has created a roadmap tracing each step in human blood stem cell development, providing a blueprint for producing fully functional blood stem cells. The map could help expand treatment options for blood cancers and inherited disorders.
Researchers have discovered that blood cancer cells steal membranes from immune cells like Natural Killer cells through a process called trogocytosis. This process allows the cancer cells to put the NK cells to sleep, shutting down their anti-cancer activity. The study also sheds light on how PD-1 inhibitors can be used to 'wake up' th...
New research found that 62% of tinted sunscreens have only one shade option, with tone compatibility being the most important criterion. The study suggests that the beauty industry and dermatologic field need to improve diversity and offer more options for tinted sunscreen formulations tailored to people with skin of color.
Researchers discovered a biomarker, S100A9, that correlates with radiotherapy response in brain cancer patients. A new drug, RAGE inhibitor, can reverse resistance to radiotherapy by targeting this mechanism.
Researchers developed a virus that infects cancer cells, killing them while sending signals to nearby uninfected cells for viral attack. This approach shrinks tumors and enhances cancer-killing efficacy in various models, including pancreatic and ovarian cancers.
Patients with mild to moderate kidney disease and kidney transplant recipients had a higher risk of cancer. They also faced a higher risk of dying from cancer, particularly from cancers such as bladder, kidney, and multiple myeloma, compared to those with normal kidney function.
Researchers found a steady decline in annual mammography use by breast cancer survivors between 2009 and 2016, with the largest decrease seen among younger patients. The study highlights the importance of reinforcing the significance of annual mammograms for breast cancer survivors.
Scientists at the University of Bath have developed a new technique called Transcription Block Survival (TBS) to accelerate the discovery of cancer-fighting drugs. TBS identifies molecules that can shut down dangerous proteins before they wreak havoc, by blocking their interaction with cell DNA.
Researchers at UC Irvine and IIT develop ALY101, a compound that blocks protein-protein interactions crucial for cancer and rare disease progression. The findings validate a new approach to structure-based drug design, with potential applications in monotherapy or combination regimens.
A recent analysis found that more than half (59%) of cancer survivors and patients experience at least a moderate level of fear of cancer recurrence. Younger people and women are disproportionately affected. Researchers emphasize the need for tailored interventions to address this common concern.
A study in rats suggests that vitamin C supplementation can help preserve skeletal muscle after doxorubicin therapy, reducing oxidative stress and inflammation. The findings suggest vitamin C may represent a promising opportunity to reduce some of the drug's most debilitating side effects.
Researchers have discovered 23 proteins in breast milk that could indicate breast cancer, paving the way for a potential blood test. The study's findings, if confirmed, may enable earlier diagnosis and improve survival rates.
A recent study found that cancer treatment side effects significantly affect patients' and caregivers' eating habits, food preferences, and overall well-being. The research team identified six themes, including managing symptoms, losing taste, and caregiver burden.
Researchers will present breakthroughs in tumor immunology, cancer drug resistance, and early detection methods. The AACR Annual Meeting features a diverse range of studies on various aspects of cancer research.
A new study found that exercising before developing cancer reduced tumor growth and cachexia symptoms in mice. Regular exercise improved cardiac structure and function, and helped slow tumor growth even after cancer was induced.
A new study suggests that cardamonin, a compound from the cardamom spice, can kill triple-negative breast cancer cells and reduce PD-L1 expression. The findings hold promise for improving cancer therapy without severe side effects.
A study analyzing blood samples from premenopausal women with breast cancer found high levels of inflammatory markers and low antioxidant levels. These findings may reveal a new diagnostic tool for the disease, with implications for identifying early stages and improving treatment outcomes.
The NCCN Annual Conference focuses on the cancer patient journey, featuring state-of-the-art practice algorithms, updates to clinical guidelines, and new therapies. Leading experts present treatment recommendations for various cancer types, including breast, colorectal, and lung cancer.
The study reveals a narrowing gap between cancer profiles in China and the USA, with converging trends in lung, breast, and colorectal cancers. China's cancer burden is expected to rise, while the US has seen reduced rates since the 1990s due to effective prevention strategies.